FDA approves second generic naloxone spray

FDA approves second generic naloxone spray
hnesich_drupal
Jun 22, 2022

The Food and Drug Administration approved the second generic naloxone nasal spray, an emergency treatment for known or suspected opioid overdose. The agency approved the first generic naloxone nasal spray in 2019.

Headline

Oh hi there 👋
It’s nice to meet you.

Sign up to receive awesome content in your inbox, every month.

We don’t spam! Read our privacy policy for more info.

Leave a comment